DEF 14AThe Ballot
Acrivon Therapeutics, Inc. files DEF 14A
Filed Apr 30, 2026 · 2mo ago · Accession 0001193125-26-194206
Plain English
Proxy statement — executive pay, board nominees, and shareholder votes.
Read the source below for the full document.
Filing details
- Company
- Acrivon Therapeutics, Inc.
- Ticker
- ACRV
- CIK
- 1781174
- Form type
- DEF 14A
- Filing date
- Apr 30, 2026
- Report date
- Jun 17, 2026
- Document
- acrv-20260430.htm
- Size
- 5.1 MB